Global Expression Vectors Market will reach USD 330.3 Million by 2021: Zion Market Research

Sarasota, FL, Dec. 28, 2016 (GLOBE NEWSWIRE) — Zion Market Research has published a new report titled “Expression Vectors Market (Bacterial, Yeast, Insect, and Mammalian) by Application (Therapeutic, Research, and Industrial) for Biotechnology & Pharmaceutical Companies, CROs & CMOs, and Academic Research End-user: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global expression vectors market was valued at approximately USD 240.7 million in 2015 and is expected to reach approximately USD 330.3 million by 2021, growing at a CAGR of around 5.4% between 2016 and 2021.

Expressions vector is the basic tool in biotechnology which is designed for gene expression in cells. The expression vector is used to introduce a specific gene into a target cell. The expression vector can commandeer the target cell’s mechanism for the production of proteins. The cloning vector containing proper expressions signals to have maximum gene expression. Different types of vector system have been developed viz. virus vector, the bacterial vector, plasmid DNA etc.

Browse through 39 Market Tables and 19 Figures spread over 110 Pages and in-depth TOC on “Global Expression Vectors Market: By Host Type, Application, Size, Share, Growth, Analysis, Segment and Forecast 2015-2021”.

Request free Sample copy of Expression Vectors Market Report @ https://www.zionmarketresearch.com/sample/expression-vectors-market

Global expression vectors market is expected to exhibit strong growth in the near future on account of the rising demand of protein-based drugs. The other key drivers influencing the growth of expression vectors market include genetic disorders, the high prevalence of infectious diseases and other diseases. Moreover, technological advancement in protein expression techniques, molecular biology, and bioinformatics is expected to propel the market growth within the forecast period. Increasing unmet medical needs due to the patent expiration of generic drugs is further projected to drive expression vectors market in order to develop novel drugs. However, high expenditure involved in research employing expression vectors may hamper the market growth in the coming years.

Bacterial, yeast, insect and mammalian expression vectors are available in the global market. In 2015, the bacterial vector was the leading segment due to high transformation levels and simple transformation protocols. The mammalian expression vectors are the key outlet of expression vector market and are expected to witness the fastest growth within the forecast period. Mammalian host systems have the ability to carry out assembly of recombinant proteins, folding, and complex post-translational modifications. 

Browse the full “Expression Vectors Market (Bacterial, Yeast, Insect, and Mammalian) by Application (Therapeutic, Research, and Industrial) for Biotechnology & Pharmaceutical Companies, CROs & CMOs, and Academic Research End-user: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021” report at https://www.zionmarketresearch.com/report/expression-vectors-market

Based on applications the expression vectors market can be segmented into therapeutic, industrial, and research applications. Therapeutic application accounted for the largest market share in 2015 and is expected to remain the fastest growing segment in the years to come. This growth is mainly due to the higher incidence rate of oncology diseases which can be treated by use of expression vectors. Research segment is expected to witness significant growth in the years to come. Technological advancement in proteomics and novel product for protein expression are expected to open up new avenues for the segment growth.

The expression vectors market is segmented on the basis of different end-user such as biotechnology & pharmaceutical companies, contract research organizations (CROs) & contract manufacturing organizations (CMOs), and academic research institutes. Biotechnology & pharmaceutical companies were the largest segment of expression vectors market in 2015 and are expected to continue its dominance in the near future. This growth is mainly due to the advancement in protein pharmaceuticals synthesis and novel drug using recombinant DNA technology.

Inquire more about this report @ https://www.zionmarketresearch.com/inquiry/expression-vectors-market

The North America regional market is by far the largest in the global expression vectors market and is set to continue to dominate the world marketplace within the forecast period. The expression vectors market is driven by the presence of research labs and production facilities of major manufacturers in this region. The rising numbers of big pharmacy firms coupled with advanced technology in the U.S. are some of the key factors that are expected to fuel the market growth in this region.

In terms of revenue, North America was followed by Europe. The therapeutic application segment is expected to propel the market growth in the years to come. This growth is mainly attributed to the increasing incidence rate of oncology diseases coupled with health awareness among people. Moreover, the adoption of new technologies is expected to witness significant growth over the forecast period. Thus, all aforementioned factors are expected to drive the demand for nanobiotechnology market in Europe.

Request a customized copy of report @ https://www.zionmarketresearch.com/custom/579

Asia Pacific is expected to fastest growing market in near future. Increasing international research collaborations, R&D expenditure, and growth in the overall healthcare industry is expected to drive growth in this region. Moreover, expression vectors market has the huge opportunity in the emerging markets of Asia Pacific due to the increasing population, rising incidence rate of oncology diseases, coupled with the rising health awareness among people especially in China and India.

The Middle East & Africa regional market is expected to witness moderate growth in the near future. The increasing demand of protein-based drugs is expected to boost the market growth in the years to come. Latin America is another important regional market and is expected to experience significant growth over the forecast period. The growth is mainly due to technological advancement in protein expression techniques, molecular biology, and bioinformatics.

Some of the key players including in the expression vectors markets such as Promega Corporation, Agilent Technologies, New England Biolabs, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Merck Millipore, QIAGEN, Clontech Laboratories, Inc., and GenScript USA Inc.

Purchase a direct copy of report with TOC @ https://www.zionmarketresearch.com/buynow/su/expression-vectors-market

This report segments the global expression vectors market as follows:

Global Expression Vectors Market: Host Analysis

  • Bacterial
  • Yeast
  • Insect
  • Mammalian 

Global Expression Vectors Market: Application Analysis

  • Therapeutic
  • Industrial
  • Research

Global Expression Vectors Market: End-user Segment Analysis 

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs) & Contract Manufacturing Organizations (CMOs)
  • Academic Research Institutes.

Global Expression vectors Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • Germany
    • France
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research

Follow Us Twitter: https://twitter.com/zion_research

CONTACT: 
Contact Us:

Joel John

4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com/

Ads